Luminus Management LLC Novan, Inc. Transaction History

Luminus Management LLC

  • $150 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$7.48 - $10.17 $4.45 Million - $6.06 Million
-595,493 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$7.8 - $17.35 $4.64 Million - $10.3 Million
595,493 New
595,493 $5.99 Million

About Novan, Inc.

NOVN Quotes by TradingView
  • Ticker NOVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,281,600
  • Market Cap $638K
  • Description
  • Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...
More about NOVN
Track This Portfolio

Track Luminus Management LLC Portfolio

Follow Luminus Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Luminus Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Luminus Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email